CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors
Moderna enters in vivo CAR-T with autoimmune asset
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
TScan Therapeutics Advances TSC-101 Toward Pivotal Trial
The Industry's Leading, Deeply Technical Flagship Cell Therapy Forum
September 15-17 2026 I Boston, MA
www.quickstat.com